Medyada yer alma

AmerisourceBergen Acclimates to the New Normal

Chain Drug Review

During these trying times, AmerisourceBergen Corp. continues to play a vital role feeding the health care supply chain and, through its global pharmaceutical health care businesses, helping combat the ongoing spread of ­COVID-19.

Rich Tremonte, executive vice president and president of community and specialty pharmacy at AmerisourceBergen, says that, like every industry, the pharmaceutical supply chain has had to adjust to these unprecedented circumstances. “We are proud of the resiliency of the supply chain and our collective efforts with manufacturers and suppliers to protect it. In March, when the coronavirus was declared a pandemic, we saw surge ordering across all classes of trade. As manufacturers navigated global restrictions, they began allocating inventory to distributors like AmerisourceBergen on a long-term basis. Additionally, we saw an increased demand for experimental treatments and products that had any semblance to supporting COVID ­patients.”

For the full article, visit Chain Drug Review

873 media mention news

Mayıs 22, 2026

Yönetici bakış açısı

873 Executive perspective News

Mayıs 22, 2026

Medyada yer alma

Nisan 23, 2026

Media contacts

Need help or have questions?  Send us a message and we'll get back to you soon.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.